Views & Analysis
deep end

In at the deep end

Pharma companies need to ‘get with the programme’ in communications, says EACA's Dominic Lyle.

Debates & Insight
NICE-logo_16-9
Sponsored

OMA at NICE: Unlocking Access One Year On

A new report by health economist Leela Barham examines how NICE’s Office for Market Access has progressed after a year in operation.

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

R&D